271 related articles for article (PubMed ID: 27836361)
1. Ultrasound-guided intrasphincteric botulinum toxin injection relieves obstructive defecation due to Hirschsprung's disease and internal anal sphincter achalasia.
Church JT; Gadepalli SK; Talishinsky T; Teitelbaum DH; Jarboe MD
J Pediatr Surg; 2017 Jan; 52(1):74-78. PubMed ID: 27836361
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
Chumpitazi BP; Fishman SJ; Nurko S
Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction.
Irani K; Rodriguez L; Doody DP; Goldstein AM
Pediatr Surg Int; 2008 Jul; 24(7):779-83. PubMed ID: 18443801
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin injection for internal anal sphincter achalasia after pull-through surgery in Hirschsprung disease.
Youn JK; Han JW; Oh C; Kim SY; Jung SE; Kim HY
Medicine (Baltimore); 2019 Nov; 98(45):e17855. PubMed ID: 31702647
[TBL] [Abstract][Full Text] [Related]
5. Comparison of posterior internal anal sphincter myectomy and intrasphincteric botulinum toxin injection for treatment of internal anal sphincter achalasia: a meta-analysis.
Friedmacher F; Puri P
Pediatr Surg Int; 2012 Aug; 28(8):765-71. PubMed ID: 22806601
[TBL] [Abstract][Full Text] [Related]
6. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: A large institutional study and review of the literature focusing on complications.
Halleran DR; Lu PL; Ahmad H; Paradiso MM; Lehmkuhl H; Akers A; Hallagan A; Bali N; Vaz K; Yacob D; Di Lorenzo C; Levitt MA; Wood RJ
J Pediatr Surg; 2019 Nov; 54(11):2305-2310. PubMed ID: 31060739
[TBL] [Abstract][Full Text] [Related]
7. Internal anal sphincter achalasia in children: clinical characteristics and treatment with Clostridium botulinum toxin.
Ciamarra P; Nurko S; Barksdale E; Fishman S; Di Lorenzo C
J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):315-9. PubMed ID: 12960655
[TBL] [Abstract][Full Text] [Related]
8. Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschsprung's disease.
Koivusalo AI; Pakarinen MP; Rintala RJ
Pediatr Surg Int; 2009 Oct; 25(10):873-6. PubMed ID: 19662428
[TBL] [Abstract][Full Text] [Related]
9. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease.
Han-Geurts IJ; Hendrix VC; de Blaauw I; Wijnen MH; van Heurn EL
J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):604-7. PubMed ID: 25000353
[TBL] [Abstract][Full Text] [Related]
10. The treatment of internal anal sphincter achalasia with botulinum toxin.
Messineo A; Codrich D; Monai M; Martellossi S; Ventura A
Pediatr Surg Int; 2001 Sep; 17(7):521-3. PubMed ID: 11666049
[TBL] [Abstract][Full Text] [Related]
11. Intrasphincteric botulinum toxin injections for post-operative obstructive defecation problems in Hirschsprung disease: A retrospective observational study.
Roorda D; Oosterlaan J; van Heurn E; Derikx J
J Pediatr Surg; 2021 Aug; 56(8):1342-1348. PubMed ID: 33288128
[TBL] [Abstract][Full Text] [Related]
12. Neurostimulation-guided Anal Intrasphincteric Botulinum Toxin Injection in Children With Hirschsprung Disease.
Louis-Borrione C; Faure A; Garnier S; Guys JM; Merrot T; Héry G; Dariel A
J Pediatr Gastroenterol Nutr; 2019 Apr; 68(4):527-532. PubMed ID: 30444834
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin injections after surgery for Hirschsprung disease: Systematic review and meta-analysis.
Roorda D; Abeln ZA; Oosterlaan J; van Heurn LW; Derikx JP
World J Gastroenterol; 2019 Jul; 25(25):3268-3280. PubMed ID: 31333317
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin injection for childhood constipation is safe and can be effective regardless of anal sphincter dynamics.
Zar-Kessler C; Kuo B; Belkind-Gerson J
J Pediatr Surg; 2018 Apr; 53(4):693-697. PubMed ID: 29395154
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease.
Langer JC; Birnbaum E
J Pediatr Surg; 1997 Jul; 32(7):1059-61; discussion 1061-2. PubMed ID: 9247234
[TBL] [Abstract][Full Text] [Related]
16. Functional outcomes in Hirschsprung disease: A single institution's 12-year experience.
Thakkar HS; Bassett C; Hsu A; Manuele R; Kufeji D; Richards CA; Agrawal M; Keshtgar AS
J Pediatr Surg; 2017 Feb; 52(2):277-280. PubMed ID: 27912977
[TBL] [Abstract][Full Text] [Related]
17. Role of rectal biopsy in predicting response to intrasphincteric botulinum toxin injection for obstructive symptoms after a pullthrough operation.
Hosseini SM; Foroutan HR; Bahador A; Khosravi MB; Geramizadeh B; Sabet B; Zeraatian S; Razmi T; Banani SJ
Indian J Gastroenterol; 2008; 27(3):99-102. PubMed ID: 18787278
[TBL] [Abstract][Full Text] [Related]
18. Histology and function of the internal anal sphincter after injection of botulinum toxin.
Langer JC; Birnbaum EE; Schmidt RE
J Surg Res; 1997 Dec; 73(2):113-6. PubMed ID: 9441803
[TBL] [Abstract][Full Text] [Related]
19. Treatment with botulinum toxin in children with chronic anal fissure.
Husberg B; Malmborg P; Strigård K
Eur J Pediatr Surg; 2009 Oct; 19(5):290-2. PubMed ID: 19746337
[TBL] [Abstract][Full Text] [Related]
20. Intrasphincteric Botox injections in Hirschsprung's disease: indications and outcome in 64 procedures over a ten-year period.
Pini Prato A; Faticato MG; Mazzola C; Arrigo S; Mattioli G; Arnoldi R; Mosconi M
Minerva Pediatr (Torino); 2023 Aug; 75(4):482-489. PubMed ID: 30419742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
